Marta Mora-Rillo

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Jonathan Grein, Norio Ohmagari, Daniel D. Shin et al. · New England Journal of Medicine · 2020 · 2.9K citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +12

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Belén Gutiérrez‐Gutiérrez, Elena Salamanca, Marina de Cueto et al. · The Lancet Infectious Diseases · 2017 · 521 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms

Elizabeth Temkin, Julián Torre‐Cisneros, Bojana Beovič et al. · Antimicrobial Agents and Chemotherapy · 2016 · 254 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Autochthonous Crimean–Congo Hemorrhagic Fever in Spain

Anabel Negredo, Fernando Calle, Eduardo Palencia-Herrejón et al. · New England Journal of Medicine · 2017 · 220 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17